Hutchinson-Gilford Progeria Syndrome (HGPS) is a progeroid disease characterized by the early onset of some classically age-related phenotypes including arthritis, loss of body fat and hair and atherosclerosis. Cells from affected individuals express a mutant version of the nuclear envelope protein Lamin A (termed Progerin) and have previously been shown to exhibit prominent chromatin changes. Here, we identify epigenetic deregulation of lamina-associated domains (LADs) as a central feature in the molecular pathology of HGPS. Using ATAC-see/-seq and Infinium MethylationEPIC BeadChip-mediated DNA methylation profiling, we demonstrate that dermal fibroblasts from HGPS patients exhibit both chromatin accessibility and DNA methylation changes that are enriched in LADs.
Introduction
The nuclear lamina is a filamentous mesh network that lines the inner nuclear membrane of metazoan nuclei. Its main component are type V intermediate filaments termed lamins, four of which, Lamin A, B1, B2 and C, are expressed in metazoan cells 1, 2 .
Over 180 mutations causing at least 13 different diseases, collectively called laminopathies, have been described for their corresponding genes 3 . One of the most severe laminopathies is Hutchinson-Gilford Progeria Syndrome (HGPS), a rare progeroid disease characterized by the early onset of some classically age-related phenotypes including osteoporosis, alopecia, loss of body fat and hair, and atherosclerosis 4, 5 . Affected individuals are usually diagnosed within the first year of life due to a failure to thrive, and suffer from rapid disease progression with death occurring in their teens as a consequence of myocardial infarction or stroke 5, 6 .
The classical form of HGPS is caused by an autosomal dominant mutation in exon 11 of the LMNA gene, which encodes both Lamin A and C 7 . The mutation activates a cryptic splice site, causing the expression of a mutant Lamin A that lacks 50 amino acids near the C-terminus while leaving Lamin C unaffected 7, 8 . The resulting truncated protein, referred to as Progerin, undergoes aberrant posttranslational modification and retains a farnesyl residue at its C-terminal CaaX motif, thus becoming permanently associated with the nuclear lamina and causing characteristic morphological changes 6 . Progerinexpressing cells have been shown to display a wide range of cellular defects such as premature cellular senescence, increased levels of reactive oxygen species, clustering of nuclear pores, delayed DNA repair and shortened telomeres 6, [9] [10] [11] [12] [13] [14] . Interestingly, low level Progerin expression has also been found in cells from normal, aged individuals, suggesting that it might play a role in normal aging as well [15] [16] [17] .
HGPS cells also exhibit a number of epigenetic aberrations. Most prominently, heterochromatin markers such as the histone modifications H3K27me3 and H3K9me3, as well as heterochromatin protein 1 (HP1) and the H3K27me3 methyltransferase EZH2, have been shown to be downregulated in fibroblasts from HGPS patients 15, 18, 19 .
Conversely, H4K20me3, another heterochromatin mark, has been reported to be increased in HGPS cells and after ectopic Progerin expression 18, 20 . Furthermore, Hi-C experiments indicate that late-passage HGPS cells lose the spatial compartmentalization of active and inactive chromatin domains present in healthy cells 19, 21 .
Less is known about the HGPS-associated role of another key epigenetic modification, DNA methylation. An earlier comparison of BJ and HGPS skin fibroblasts using bisulfite padlock probes, a method for the targeted quantification of DNA methylation at a limited number of CpGs 22 , identified 586 differentially methylated autosomal genes in HGPS 23 . Another study reported profound DNA methylation changes in a set of agerelated genes in HGPS patients 24 . However, the authors used samples of adult onset, i.e., non-classical progeria, for their comparisons 24 , thus leaving the question of DNA methylation alterations in classical HGPS unanswered. Finally, it was recently demonstrated that HGPS fibroblasts from some patients exhibit an increased 'DNA methylation age' (an estimate of the biological age computed on the basis of the methylation status of 391 genomic loci) 25 , hence suggesting a considerable degree of underlying epigenetic changes. A comprehensive characterization of these aberrations in classical HGPS, however, remains to be performed.
A potential candidate for epigenetic changes in HGPS are lamina-associated domains (LADs), i.e., regions of the DNA that are in close contact with the nuclear lamina.
They are considered to assist in the spatial organization of the genome and to exert a role in gene repression [26] [27] [28] . Importantly, LADs largely overlap with late-replicating regions 26, 27 , are mostly gene-poor 26 
Results

ATAC-see and ATAC-seq reveal genome-wide chromatin accessibility changes enriched in lamina-associated domains (LADs)
We obtained primary skin fibroblasts from nine progeria patients and six controls (Suppl. Tab. 1). We tested all these cell lines for characteristic nuclear morphology changes and Progerin expression at the transcript and protein levels. Specifically, HGPS fibroblasts exhibited a wide range of nuclear malformations including characteristic wrinkling and lobulation of the nuclear lamina (Suppl. Fig. 1A) . Importantly, the fraction of cells showing nuclear malformations ranged from 30-89% in HGPS cells, but only from 3-15% in control cells (Suppl. Fig. 1B ). In addition, expression of Progerin as a consequence of an upregulation of the ∆150 LMNA transcript was readily detected in all HGPS, but not in control samples (Suppl. Fig. 1C-F) .
In order to obtain further insight into the extent of epigenetic aberrations in HGPS cells, we imaged the transposase-accessible genome in HGPS and control fibroblasts using ATAC-see 33 . Through the insertion of fluorophores by the Tn5 transposase at open chromatin sites, this technique allows the visualization of accessible chromatin using microscopy. Interestingly, whereas bright foci representing highly accessible chromatin regions were detected in 82-91% of control cell nuclei, only 34-53% of HGPS nuclei revealed these foci (Figs. 1A and 1B, P=1.43e-2, unpaired t-test). Moreover, the number of foci was negatively correlated with the number of malformed nuclei in HGPS cells (R 2 = 0.30), suggesting that HGPS-related nuclear malformation has an effect on chromatin accessibility (Fig. 1C ).
To further investigate this possibility and to quantify the magnitude of changes in HGPS fibroblasts, we globally profiled the accessible genome in HGPS cells using ATACseq. This identified 546 significantly differentially accessible regions between HGPS and control fibroblasts, of which 398 and 148 gained and lost accessibility in HGPS, respectively (q<0.05, Benjamini-Hochberg, Fig. 1D and Suppl. Fig. 2A ). About one half of the differentially accessible regions were located in genes, about one third mapped to intergenic regions and a minor fraction to active and poised enhancers (Fig. 1E ).
Interestingly, we found several lines of evidence suggesting that genomic regions in contact with the nuclear lamina, especially those associated with Lamin A, undergo substantial alterations in chromatin accessibility in HGPS cells. First, Lamin A-, but not (Fig. 1F) . Second, regions associated with the active chromatin marks H3K4me3 (P<2.20e-16), H3K27ac (P=2.30e-3) and H3K36me3 (P=5.88e-06) were significantly underrepresented among the differentially accessible regions, whereas regions associated with the repressive chromatin mark H3K9me3 (P=3.70e-4) were slightly overrepresented (Fisher's Exact test for all, Suppl. Fig. 2B ). Third, we observed that the relatively gene-poor chromosome 18, which tends to be located near the nuclear periphery and shows multiple LAD contacts in proliferating cells 34, 35 , exhibited more than 7 times more differentially accessible regions than the similarly sized, gene-rich, and more centrally located chromosome 19 (Suppl. Fig. 2C ). Finally, we found that binding sites of members of the Activator Protein 1 (AP1) family of transcription factors, which have previously been shown to be associated with the nuclear lamina in mammalian cells 36 
DNA methylation profiling in HGPS reveals two patient subgroups and LADenriched hypermethylation
Loss of DNA methylation in lamina-associated, late-replicating regions known as PMDs has recently been shown to constitute a biomarker of cellular aging 32 . To investigate whether the LAD-specific chromatin accessibility changes in HGPS cells are accompanied by alterations in DNA methylation, we performed DNA methylation profiling using Infinium MethylationEPIC BeadChips, which capture the methylation status of more than 850,000
CpGs in the human genome.
After batch correction and removal of sex chromosome-associated probes we identified 19,759 differentially methylated (P<0.05, F-test) probes between nine HGPS and six control samples ( Fig. 2A) . Unsupervised consensus clustering of the 5,000 most variably methylated probe clusters separated the samples into three groups: while the controls formed one uniform group, the HGPS samples were split into two subgroups ( Fig.   2B and Suppl. Fig. 3A ). This substructure was not associated with patient age, body site of sampling, sex, strength of Progerin expression or passage number. However, it was in agreement with a subclassification of HGPS samples based on a recently reported DNA methylation age acceleration in some HGPS patients 25 . When we applied the corresponding age estimator to our sample set, the samples were divided into an ageaccelerated group (median ∆ age = 9.73 years) and a group with a slight age deceleration (median ∆ age = -1.51 years), which overall matched the two subgroups identified through consensus clustering (Fig. 2C ). This finding suggests that individual HGPS patients differ significantly with regard to their DNA methylation patterns and that this epigenetic modification may represent a novel tool for the classification of affected individuals.
Of note, most of the 5,000 most variable probe clusters used for the subgrouping contained probes located in genes and intergenic regions, while only a few were located in CpG islands and promoters ( One of the major epigenetic alterations known in HGPS is the loss of heterochromatin-associated histone marks at the nuclear periphery of Progerin-expressing cells 15, 18, 19 . We therefore tested whether DNA methylation is similarly altered in genomic regions associated with the nuclear lamina. While we only found a small increase in median methylation levels of all 850,000 EPIC probes, Lamin A LAD-associated probes exhibited a strong and significant (P<2.20e-16, Welch Two Sample t-test) increase ( exhibited only minor changes (Fig. 2D) . Altogether, these results indicate that DNA methylation changes in HGPS cells occur primarily in lamina-associated, partially methylated regions and are distinct from changes found during normal aging.
Epigenetic deregulation of LADs contributes to aberrant gene expression in HGPS
To investigate whether the identified LAD-specific chromatin accessibility and DNA methylation changes contribute to aberrant gene expression in HGPS cells, we performed RNA sequencing (RNA-seq) using fibroblasts from six HGPS patients and three controls.
A total of 343 genes were found to be significantly (q<0.05, Benjamini-Hochberg)
differentially expressed between HGPS and control cells, of which 160 were upregulated and 183 were downregulated in HGPS, respectively (Fig. 3A) . Importantly, many of these genes, especially those more strongly deregulated, overlapped with genes previously identified to be differentially expressed in HGPS 11,41 (Suppl. Fig. 4A ).
Gene Ontology (GO) analysis suggested 'organismal' and 'developmental' processes as well as 'signaling' and 'cell communication' as the main pathways to be affected by these changes (Suppl. Fig. 4B ). In addition, Gene Set Enrichment Analyses (GSEA) highlighted Hippo signaling, ECM receptor interaction, UV response and Notch signaling, among others, to be significantly overrepresented in the set of differentially regulated genes (Fig. 3B and Suppl. Fig. 4C ). TRANSFAC analysis of putative upstream regulators identified NRF2 as the main transcription factor associated with these changes (Fig. 3C) . Importantly, NRF2 has previously been reported to be sequestered to the nuclear lamina by Progerin and to cause a subset of HGPS-associated expression changes 11 .
Given the rapid progression of age-related pathologies in HGPS patients, we also wondered whether cells from young and older patients differ significantly with regard to PDK4  DNER  KCNQ3  FAM19A2  TRPC3  CHST8  FAM84A  ESYT3  PRKG2  SP9  LOC285084  KCNS3  LINC00856  DIRAS3  KCNK1  MMP10  S1PR1  MALL  IL13RA2  SPON2  DPP4  DPT  ALDH1A3  CDH3  PALD1  ROS1  DBH  GNAO1  SLC24A3  CPA3  ZNF423  RASGRP1  GGT5  MAB21L1  PLXDC1  PDE3A  COL4A5  F2RL2  FAM212B  LRRC17  PPP1R14A  PEAR1  SCUBE3  F2R  INHBA  NTN4  OLFM2 their expression patterns. Indeed, deregulated genes in younger patients (<8 years) were associated with the GO terms 'embryonic skeletal system development' and 'anterior/posterior pattern specification' (Fig. 3D and Suppl. Fig. 4D ). In comparison, differentially expressed genes in older patients (>8 years) were associated with typical HGPS-related pathological features including 'glomerulus development', 'endothelium development', 'regulation of blood pressure', 'angiogenesis', and 'muscle system process' (Fig. 3D and Suppl. Fig. 4D ). In conclusion, both HGPS-related developmental aberrancies and the worsening of disease pathology can be tracked at the level of gene expression in vitro.
To test whether LAD-associated epigenetic changes contribute to the gene expression patterns observed in HGPS fibroblasts, we compared the RNA-seq datasets with the DNA methylation and ATAC-seq datasets. Of the 343 genes with significant expression changes, 21 showed simultaneous changes in accessibility in HGPS (Suppl. To further confirm the epigenetic deregulation of LADs in HGPS, we performed fluorescence in situ hybridization (FISH) experiments in HGPS fibroblast nuclei. More specifically, we measured the distance of EDIL3 and IGFBP7-specific FISH signals to the nuclear lamina (Fig. 3F, lower panel) . The former encodes an integrin ligand with an important role in angiogenesis, as well as in vessel wall remodeling and development 42, 43 ;
the latter encodes a member of the insulin-like growth factor-binding protein (IGFBP) family and is related to cellular senescence and modulation of angiogenesis [44] [45] [46] 
Discussion
Previous studies have reported widespread histone modification changes in HGPS cells 15, 18, 19 , but little is known about their effect on chromatin accessibility and their relationship to DNA methylation patterns. To explore the nature and extent of potential alterations in these regulatory layers, as well as their influence on disease-specific gene expression, we subjected primary dermal fibroblasts from different HGPS patients to an integrated analysis using ATAC-see/-seq, DNA methylation profiling and RNA-seq. Our data reveal epigenetic deregulation of LADs as a novel, defining feature of the HGPS epigenome, which simultaneously contributes to aberrant gene expression in the disease.
We found HGPS-specific chromatin accessibility and DNA methylation changes to be significantly enriched in genomic regions that are in contact with the nuclear lamina in normal dermal fibroblasts 26, 47 . This enrichment was observed for both regions gaining and losing accessibility in the disease, thus indicating considerable re-configuration of LADs largely overlap with PMDs, which have been shown to exhibit reduced levels of DNA methylation as a consequence of mitotic aging 32 . Surprisingly, however, in HGPS cells we observed an increase of median methylation levels in these regions, specifically those associated with Lamin A. As most of the DNA methylation changes in HGPS cells occurred in gene bodies and intergenic regions (Fig. 2B) , we interpret our results to reflect a HGPS-specific relocalization of formerly LAD-associated regions within the nucleus, leading to higher gene expression and concomitant DNA methylation changes as observed in the case of the EDIL3 and IGFBP7 loci. Such a conclusion is supported by the finding that gene expression positively correlates with increased gene body methylation 48 .
Our results also indicate that considerable DNA methylation differences exist not only between HGPS and control samples, but also within the group of patient fibroblasts.
Intriguingly, these are manifested in a DNA methylation age acceleration for some patients, but not others (Fig. 2C) . Despite small deviations, which are likely to be attributable to differences in the number of population doublings, our DNA methylation age estimates closely resemble recently published data for the same samples with the exception of HGADFN143 25 . However, we detected no or very limited differences between the two groups with regard to chromatin accessibility and gene expression, respectively, and the extent of these changes did not match those observed between HGPS and control cells (data not shown). While this is likely to be a consequence of the relatively low number of samples from both groups used for the comparisons, further studies are necessary to better decipher the molecular implications of the detected DNA methylation alterations in HGPS cells.
Although HGPS fibroblasts exhibited a substantial number of differentially expressed genes, the effect of LAD-related chromatin accessibility and DNA methylation changes on gene expression was limited. While this is in line with the observation that LADs are generally gene-poor 26 , it also suggests that other mechanisms are likely to contribute to the aberrant gene expression of HGPS cells. In this regard, NRF2 mislocalization to the nuclear lamina has recently been demonstrated to be a key contributor to the HGPS-specific transcriptome 11 . Our data are in agreement with this finding, since we identified the transcription factor as one of the key factors responsible for the HGPS-related gene expression changes, even though its target genes did not reach statistical significance (FDR q-val<0.05) in our GSEA analyses (Suppl. Fig. 4C ).
Furthermore, NRF2 binding motifs were significantly (q=1.80e-3, Benjamini-Hochberg) enriched in the differentially accessible regions between HGPS and control cells (Suppl. Fig. 2E ). Because the transcription factor has been shown to be sequestered to the nuclear lamina by Progerin 11 , it is tempting to speculate that the epigenetic changes observed in LADs are involved in the NRF2-mediated differential expression in the disease.
The nuclear lamina is known to be a resting place for transcription factors, serving to sequester them away from chromatin 49 . c-Fos, a member of the AP1 family of transcription factors, for example, is negatively regulated by binding to Lamin A/C at the nuclear lamina 36 . This function might be impaired by the presence of Progerin in HGPS cells, since we found AP1 members to constitute the transcription factor family that is most affected by the epigenetic deregulation in HGPS (Fig. 1G, Suppl. Fig. 3D ). Intriguingly, both IGFBP7 and EDIL3 contain consensus binding sites for AP1 family members in their respective promoter or enhancer 45, 50 , further indicating that their differential expression is likely driven by epigenetic changes in HGPS cells.
In summary, our results suggest a scenario, in which the Progerin-driven nuclear malformation of HGPS nuclei causes substantial, but potentially locally stochastic epigenetic re-configuration of LAD-specific chromatin (Fig. 4) . As peripheral heterochromatin is diminished in these cells 15, 18, 19 , many of the affected regions gain a more relaxed chromatin environment that is more permissive to the binding of transcription factors and might thus facilitate differential expression. In some cases, chromatin decondensation and disease-specific differential expression of formerly LAD-associated loci accompanies their relocalization within the nucleus (Fig. 4) , as detected for EDIL3 and
IGFBP7.
Further experiments are needed to clarify whether similar mechanisms contribute to disease-specific gene expression in other tissues and whether they are also active in classical aging. Progerin-driven nuclear malformation in HGPS nuclei causes substantial, but potentially locally stochastic epigenetic reconfiguration of LAD-specific chromatin. As peripheral heterochromatin is diminished in these cells, many of the affected regions gain a more relaxed chromatin environment that is more permissive to the binding of transcription factors and might thus facilitate differential expression. In some cases, chromatin decondensation and disease-specific differential expression of formerly LAD-associated loci coincides with their relocalization within the nucleus, as detected in the case of EDIL3 and IGFBP7. 
Methods
ATAC-see
Hyperactive Tn5 transposase production and Tn5 transposome assembly using Atto-590N-labeled oligonucleotides were carried out as described previously 33 . Cells were grown on cover slips until 70-80% confluence and fixed with 3.8% paraformaldehyde (PFA) for 10 minutes at room temperature. They were then permeabilized with lysis buffer 
ATAC-seq
ATAC-seq was performed as described previously 51 . Briefly, 50,000 cells were Subsequently, samples were purified using the MinElute PCR Purification kit (Qiagen).
Final libraries were then PCR-amplified, purified once again with the same kit and subjected to paired-end sequencing on a HiSeq 4000 platform (Illumina).
Reads were trimmed by removing stretches of bases having a quality score of <30 at the ends of the reads. The reads were mapped using Bowtie 2 52 against the hg19 assembly of the human genome. Peaks were called using MACS2 53 and differential peaks were quantified by DESeq2 54 .
Distribution of significant, non-sex chromosome-associated ATAC-seq peaks across the genome was determined using the subsetByOverlaps and Genomic Regions 26, 47 . Poised enhancers for dermal fibroblasts were defined as regions containing pairs of H3K4me1 peaks in close proximity (<1,500 bp) using ENCODE ChIP-seq data (ENCSR000ARV); active enhancers were obtained directly from ENCODE (ENCSR871EJM). Transcription factor binding sites overlapping with significant, non-sex chromosome-associated ATAC-seq peaks were determined using the HOMER motif analysis tool 55 .
DNA methylation analysis
DNA methylation profiles were generated using Infinium MethylationEPIC BeadChips (Illumina), following the manufacturer's instructions. Methylation data analysis was carried out using the R Bioconductor package Minfi (v1.20.2) 56 . Specifically, raw .IDAT files were read and preprocessed. Methylation loci (probes) were filtered for high detection p-value (P>0.01, as provided by Minfi), location on sex chromosomes, ability to selfhybridize, and potential SNP contamination. Array normalization was performed using the preprocessFunnorm function, available in Minfi 56 . Quality control was performed after every preprocessing step. Subsequently, differentially methylated probes were identified by fitting a linear model followed by statistical analysis using an empirical Bayes method to moderate standard errors. Lastly, differentially methylated probes were filtered by significance threshold (P<0.05, F-test, after correction for multiple testing using the Benjamini-Hochberg method).
For consensus clustering, probe clusters were identified using the Minfi function boundedClusterMaker with a maximum cluster width of 1,500 bp and a maximum gap of 500 bp. Using the ConsensusClusterPlus package 57 , consensus clustering was performed with the 5,000 most variable probe clusters, i.e., the 5,000 probe clusters having the highest standard deviation, with the following parameters: maxK = 6; reps = 1,000; pItem = 0.8; and pFeature = 1. Samples were then assigned to the optimal number of clusters, and (1 mg/ml) (Invitrogen) and resuspended in 15 µl of hybridization buffer (10% dextran sulfate, 50% formamide, 2x SSC pH 7). Ultimately, FISH was performed as previously described 61 . Slides were imaged using Zeiss Axioskop 2 and Olympus FluoView FV1000 microscopes. For each probe, images were acquired for 60 cells. Distance measurements were performed with Fiji 62,63 using confocal sections with a clear FISH signal. For groupspecific comparisons, the respective HGPS and control sample data were pooled and subjected to a Welch Two Sample t-test with a 95% confidence interval in R. Reads were trimmed by removing stretches of bases having a quality score of <30
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at the ends of the reads. The reads were mapped using Tophat 2.0.6 64 against the hg19 assembly of the human genome. Differential expression was quantified using DESeq2 54 and Cuffdiff 2.0 65 and subjected to multiple testing corrections. Genes with a q-value smaller than 0.05 were considered differentially expressed.
Gene ontology (GO) analyses were performed using the AmiGO 2 database [66] [67] [68] .
TRANSFAC analyses were carried out using the TRANSFAC® Public 6.0 database in Match -1.0 69 . Gene Set Enrichment Analysis (GSEA) 70 
